IRIS Accounts Production v25.1.4.42 05988888 director 1.12.23 30.11.24 30.11.24 false true false false true false Ordinary 1.00000 Ordinary C 1.00000 Ordinary D 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh059888882023-11-30059888882024-11-30059888882023-12-012024-11-30059888882022-11-30059888882022-12-012023-11-30059888882023-11-3005988888ns15:EnglandWales2023-12-012024-11-3005988888ns14:PoundSterling2023-12-012024-11-3005988888ns10:Director12023-12-012024-11-3005988888ns10:PrivateLimitedCompanyLtd2023-12-012024-11-3005988888ns10:SmallEntities2023-12-012024-11-3005988888ns10:AuditExempt-NoAccountantsReport2023-12-012024-11-3005988888ns10:SmallCompaniesRegimeForDirectorsReport2023-12-012024-11-3005988888ns10:SmallCompaniesRegimeForAccounts2023-12-012024-11-3005988888ns10:FullAccounts2023-12-012024-11-3005988888ns10:OrdinaryShareClass12023-12-012024-11-3005988888ns10:OrdinaryShareClass22023-12-012024-11-3005988888ns10:OrdinaryShareClass32023-12-012024-11-3005988888ns5:CurrentFinancialInstruments2024-11-3005988888ns5:CurrentFinancialInstruments2023-11-3005988888ns5:ShareCapital2024-11-3005988888ns5:ShareCapital2023-11-3005988888ns5:RetainedEarningsAccumulatedLosses2024-11-3005988888ns5:RetainedEarningsAccumulatedLosses2023-11-3005988888ns10:RegisteredOffice2023-12-012024-11-3005988888ns5:FurnitureFittings2023-11-3005988888ns5:FurnitureFittings2023-12-012024-11-3005988888ns5:FurnitureFittings2024-11-3005988888ns5:FurnitureFittings2023-11-3005988888ns5:WithinOneYearns5:CurrentFinancialInstruments2024-11-3005988888ns5:WithinOneYearns5:CurrentFinancialInstruments2023-11-3005988888ns10:OrdinaryShareClass12024-11-3005988888ns10:OrdinaryShareClass22024-11-3005988888ns10:OrdinaryShareClass32024-11-30059888881ns10:Director12023-11-30059888881ns10:Director12022-11-30059888881ns10:Director12023-12-012024-11-30059888881ns10:Director12022-12-012023-11-30059888881ns10:Director12024-11-30059888881ns10:Director12023-11-30
REGISTERED NUMBER: 05988888 (England and Wales)















Unaudited Financial Statements for the Year Ended 30th November 2024

for

Cutisadvance Ltd

Cutisadvance Ltd (Registered number: 05988888)






Contents of the Financial Statements
for the Year Ended 30th November 2024




Page

Balance Sheet 1

Notes to the Financial Statements 2


Cutisadvance Ltd (Registered number: 05988888)

Balance Sheet
30th November 2024

30.11.24 30.11.23
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 2,846 2,868

CURRENT ASSETS
Debtors 5 64,351 46,588
Cash at bank 145,155 136,776
209,506 183,364
CREDITORS
Amounts falling due within one year 6 10,842 12,080
NET CURRENT ASSETS 198,664 171,284
TOTAL ASSETS LESS CURRENT
LIABILITIES

201,510

174,152

PROVISIONS FOR LIABILITIES 541 553
NET ASSETS 200,969 173,599

CAPITAL AND RESERVES
Called up share capital 7 1,021 1,021
Retained earnings 199,948 172,578
SHAREHOLDERS' FUNDS 200,969 173,599

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30th November 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30th November 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the director and authorised for issue on 29th August 2025 and were signed by:





Dr K Taghipour - Director


Cutisadvance Ltd (Registered number: 05988888)

Notes to the Financial Statements
for the Year Ended 30th November 2024

1. COMPANY INFORMATION

Cutisadvance Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 05988888

Registered office: The Lexicon
Mount Street
Manchester
M2 5NT

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Related party
Transactions took place between the Company and The Harley Street Mole Mapping Clinic Ltd where Dr Taghipour is a director with a 50% shareholding.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Revenue from the provision of professional services is recognised on delivery of the service.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Tangible Fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment loss.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following basis:

Fixtures, Fittings and Equipment - 25% on cost

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Cutisadvance Ltd (Registered number: 05988888)

Notes to the Financial Statements - continued
for the Year Ended 30th November 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2023 - 1 ) .

4. TANGIBLE FIXED ASSETS
Fixtures
and
fittings
£   
COST
At 1st December 2023 6,063
Additions 1,683
At 30th November 2024 7,746
DEPRECIATION
At 1st December 2023 3,195
Charge for year 1,705
At 30th November 2024 4,900
NET BOOK VALUE
At 30th November 2024 2,846
At 30th November 2023 2,868

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Trade debtors 6,783 3,271
Other debtors 44,800 43,000
Directors' current accounts 12,768 317
64,351 46,588

Other debtors relates to a loan to The Harley Street Mole Mapping Clinic Ltd. where Dr Taghipour is a director with a 50% shareholding.

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.11.24 30.11.23
£    £   
Corporation tax 8,795 10,007
Accrued expenses 2,047 2,073
10,842 12,080

Cutisadvance Ltd (Registered number: 05988888)

Notes to the Financial Statements - continued
for the Year Ended 30th November 2024

7. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.11.24 30.11.23
value: £    £   
1,000 Ordinary £1 1,000 1,000
10 Ordinary C £1 10 10
11 Ordinary D £1 11 11
1,021 1,021

Ordinary Shares confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

Ordinary C and D Shares do not confer on the holders the right to vote upon any resolution proposed at any general meeting of the company.

The A , C and D shares rank pari passu in terms of dividend.

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 30th November 2024 and 30th November 2023:

30.11.24 30.11.23
£    £   
Dr K Taghipour
Balance outstanding at start of year 317 451
Amounts advanced 75,398 41,776
Amounts repaid (62,947 ) (41,910 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 12,768 317

The loan is repayable on demand and no interest was charged during the year.

9. CONTROL

The ultimate controlling party is Dr K Taghipour by virtue of her 100% holding of the voting share capital.